• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of dysphonia caused by amikacin liposome inhalation in complex pulmonary disease.

作者信息

Kurahara Y, Kanaoka K, Tanaka Y, Maeda Y, Kobayashi T, Takeuchi N, Kagawa T, Tachibana K, Yoshida S, Tsuyuguchi K

机构信息

Department of Internal Medicine, Department of Infectious Diseases, and, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka.

Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka.

出版信息

Int J Tuberc Lung Dis. 2023 Aug 1;27(11):872-873. doi: 10.5588/ijtld.23.0275.

DOI:10.5588/ijtld.23.0275
PMID:37880889
Abstract
摘要

相似文献

1
Management of dysphonia caused by amikacin liposome inhalation in complex pulmonary disease.阿米卡星脂质体吸入治疗复杂肺部疾病所致发音障碍的管理
Int J Tuberc Lung Dis. 2023 Aug 1;27(11):872-873. doi: 10.5588/ijtld.23.0275.
2
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Complex (CONVERT). A Prospective, Open-Label, Randomized Study.卷曲霉素脂质体吸入混悬液治疗复杂（CONVERT）引起的治疗抵抗性肺病。一项前瞻性、开放标签、随机研究。
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC.
3
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.硫酸卷曲霉素脂质体吸入混悬液治疗鸟分枝杆菌复合体肺病的研究进展
Drugs. 2019 Apr;79(5):555-562. doi: 10.1007/s40265-019-01095-z.
4
Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.卷曲霉素脂质体吸入混悬液治疗难治性鸟分枝杆菌复合群肺病：使用情况概述。
Clin Drug Investig. 2021 Apr;41(4):405-412. doi: 10.1007/s40261-021-01010-z. Epub 2021 Mar 16.
5
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.阿米卡星脂质体吸入混悬液治疗难治性鸟分枝杆菌复合群肺病：培养转换的可持续性和耐久性及长期暴露的安全性。
Chest. 2021 Sep;160(3):831-842. doi: 10.1016/j.chest.2021.03.070. Epub 2021 Apr 19.
6
Acquisition of Amikacin Resistance during Amikacin Liposome Inhalation Suspension Add-on Therapy for Complex Pulmonary Disease.在阿米卡星脂质体吸入混悬液辅助治疗复杂肺部疾病期间获得阿米卡星耐药性。
Ann Am Thorac Soc. 2024 Mar;21(3):526-529. doi: 10.1513/AnnalsATS.202305-454RL.
7
Amikacin Liposome Inhalation Suspension for Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial.阿米卡星脂质体吸入混悬液治疗复杂肺部疾病：一项为期 12 个月的开放性标签扩展临床试验。
Ann Am Thorac Soc. 2021 Jul;18(7):1147-1157. doi: 10.1513/AnnalsATS.202008-925OC.
8
Liposomal Amikacin Inhalation Suspension-induced Pneumonitis.脂质体阿米卡星吸入混悬液诱发的肺炎
Intern Med. 2022 Aug 15;61(16):2547-2549. doi: 10.2169/internalmedicine.8796-21. Epub 2022 Feb 1.
9
Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection.吸入阿米卡星治疗难治性鸟分枝杆菌复合群感染所致的喉部损伤
Chest. 2021 Apr;159(4):e185-e187. doi: 10.1016/j.chest.2020.11.045. Epub 2021 Apr 6.
10
Amikacin Liposome Inhalation Suspension as a Treatment Option for Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium avium Complex.阿米卡星脂质体吸入混悬液作为鸟分枝杆菌复合体引起的难治性非结核分枝杆菌肺病的一种治疗选择。
Mayo Clin Proc. 2020 Jan;95(1):201-202. doi: 10.1016/j.mayocp.2019.10.024.

引用本文的文献

1
Effects of Amikacin Liposome Inhalation Suspension and Amikacin Resistance Development in Patients With Refractory Complex Pulmonary Disease.阿米卡星脂质体吸入混悬液对难治性复杂性肺部疾病患者的影响及阿米卡星耐药性的发展
Open Forum Infect Dis. 2025 Mar 1;12(3):ofaf118. doi: 10.1093/ofid/ofaf118. eCollection 2025 Mar.
2
Comprehensive Management Algorithm for Complex Pulmonary Disease in the Real-World Setting.真实世界中复杂肺部疾病的综合管理算法
Ann Am Thorac Soc. 2025 May;22(5):651-659. doi: 10.1513/AnnalsATS.202408-904FR.